Abstract
Cubosomes encapsulating fluconazole were prepared by emulsification method and characterized for particle size, entrapment efficiency, SEM, in vitro release, skin irritation studies, and confocal laser scanning microscopy. The cubosomes prepared were 257.2 ± 2.94 nm in size and with drug entrapment efficiency of 66.2 ± 2.69 %. The prepared formulation was characterized for surface morphology by SEM analysis which revealed their smooth surface. The cumulative percentage of fluconazole from cubosomes permeated via dialysis membrane (molecular weight cutoff (MWCO) 12–14 kD) showed 76.86 % cumulative drug release, while fluconazole solution showed release up to 91.04 % in 24 h in phosphate-buffered saline (PBS) (pH 6.5), and sustained release is obtained after 24 h in case of cubosomes. The animal studies also revealed that the cubosomes are non-irritant and have sustained antifungal activity.
Similar content being viewed by others
References
Abdel-Mottaleb MM, Mortada ND, El-Shamy AA, Awad GA. Physically cross-linked polyvinyl alcohol for the topical delivery of fluconazole. Drug Dev Ind Pharm. 2009;35:311–20.
Anderson DM, Wennerstrom H. Self-diffusion in bicontinuous cubic phases, L3 phases, and microemulsions. J Phys Chem. 1990;94:8683–94.
Angulo I, Jimenez-Dıaz MB, Garcıa-Bustos JF, Gargallo D, Heras FGDL, Munoz-Fernandez MA, et al. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immun. 2002;218:46–58.
M Arevalo MP, Arias A, Andreu A, Rodriguez C, Sierra A. (1994) Fluconazole, itraconazole and ketoconazole in vitro activity against Candida species. J. Chemother. 6:226–29
Bei D, Zhang T, Murowchick JB, Youan BC. Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. AAPS PharmSciTech. 2010;11:3.
Betz G, Nowbakht P, Imboden R, Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulation in vitro. Int J Pharm. 2001;228:147–59.
Boyd BJ, Khoo SM, Whittaker DV. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poor water soluble drug in rats. Int J Pharm. 2007;340(1/2):52–60.
Carr MG, Corish J, Corrigan OI. Drug delivery from a liquid crystalline base across Visking and human stratum corneum. Int J Pharma. 1997;157:35–42.
Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning, et al. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother. 2006;57:384–410.
Dian L, Yang Z, Li F, Wang Z, Pan X, Peng X, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomed. 2013;8:845–54.
Drummond CJ, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci. 2000;4:449–56.
Fu K, Izquierdo R, Vandevender D, Warpeha RL, Farced J. Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model. Thromb Res. 1997;86:355–61.
Garg G, Saraf S, Saraf S. Cubosomes: an overview. Biol Pharm Bull. 2007;30(2):350–3.
Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. 1990;39:877–916.
Gupta M, Goyal AK, Paliwal SR, Paliwal R, Mishra N, Vaidya B, et al. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res. 2010;20(4):341–50.
Gustafson J, Lusberg-Wharen H, Almgrem M, Larson K. Submicron particle of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir. 1997;13:6964–79.
Jain A, Mehra NK, Nahar M, Jain NK. Topical delivery of enoxaparin using nanostructured lipid carrier. J Microencapsul. 2013;30(7):709–15.
Laithy HMEI, EI-Shaboury KMF. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS Pharmsci. 2002;3:1–9.
Maebashi K, Toyama T, Uchida K, Yamaguchi H. A novel model of cutaneous candidiasis produced in prednisolone-treated guinea pigs. J Med Vet Mycol. 1995;19:390–2.
Martin MV. The use of fluconazole and itraconazole in the treatment of Candida albicans infection: a review. J Antimicrob Chem. 1999;44:429–37.
Ning MY, Guo YZ, Pan HZ, Chen X, Zhongwei G. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 2005;31:375–83.
Ning MY, Guo YZ, Pan HZ, Yu HM, Gu ZW. Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull. 2005;53:620–24.
Sagar GH, Arunagirinathan MA, Bellare JR. Self assembled surfactant nano-structures important in drug delivery: a review. Ind J Exp Biol. 2007;45:133–59.
Satturwar PM, Khandare JN, Nande VS. Niosomal delivery of ketoconazole. Ind Drugs. 2001;38:620–4.
Schwartz J, Moreno E, Fernández C, Navarro-Blasco E, Nguewa PA, Palop JA, et al. Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation. Eur J Pharma Sci. 2014;62:309–16.
Schwartz JB, Simonelli AP, Higuchi WI. Drug release from wax matrices. I. Analysis of data with first-order kinetics and with the diffusion-controlled model. J Pharm Sci. 1968;57:274–7.
Singh M, Singh MP, Maiti SN, Gandhi A, Micetich RG, Atwal H. Preparation of liposomal fluconazole and their in-vitro antifungal activity. J Microencapsul. 1993;10:229–36.
Wohlarb W, Lasch J. Penetration kinetics of liposomal hydrocortisone in human skin. Dermatol. 1987;174:18–22.
Zakir F, Vaidhya B, Goyal AK, Malik B, Vyas SP. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Delivery. 2010;17(4):238–48.
Acknowledgments
All the authors are thankful to AIIMS, New Delhi, for SEM facility and RGPV, Bhopal, for DSC studies. One of the authors, Ms. Aakanchha Jain, wishes to acknowledge Dr. Shushant Shrivastava, BHU, Varanasi, for CLSM facilities and to INSPIRE DST for Ph.D. fellowship. One of the authors, Dr. Richa Jain, is thankful to SJPN, Peoples Group, Bhopal.
Conflict of interest
All the authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prajapati, V., Jain, A., Jain, R. et al. Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes. Drug Deliv. and Transl. Res. 4, 400–408 (2014). https://doi.org/10.1007/s13346-014-0202-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-014-0202-2